All studies showed that there was a decrease in the prevalence of AMD‐related visual impairment after the introduction of anti‐VEGF injections (Bloch et al., 2012; Bunce et al., 2015; Jeffery, Mukhtar, Lopez, et al., 2021; Purola et al., 2023; Rees et al., 2014). The gene discussed is VEGFA; the disease is age-related macular degeneration.